PCMI
Paradigm Capital Management Inc Portfolio holdings
AUM
$2.05B
This Quarter Return
+15.8%
1 Year Return
+12.74%
3 Year Return
+134.07%
5 Year Return
+283.66%
10 Year Return
+799.95%
AUM
$1.51B
AUM Growth
+$1.51B
(+8.7%)
Cap. Flow
-$45.7M
Cap. Flow
% of AUM
-3.02%
Top 10 Holdings %
Top 10 Hldgs %
40.49%
Holding
150
New
5
Increased
19
Reduced
36
Closed
6
Top Buys
| 1 |
Coherent
COHR
|
$12M |
| 2 |
SI-BONE Inc
SIBN
|
$8.6M |
| 3 |
Entegris
ENTG
|
$6.11M |
| 4 |
MaxLinear
MXL
|
$5.17M |
| 5 |
Enviri
NVRI
|
$5.05M |
Top Sells
| 1 |
FormFactor
FORM
|
$13.3M |
| 2 |
Veeco
VECO
|
$13.2M |
| 3 |
Cohu
COHU
|
$12.3M |
| 4 |
Ribbon Communications
RBBN
|
$10.6M |
| 5 |
Cerence
CRNC
|
$9.51M |
Sector Composition
| 1 | Technology | 58.25% |
| 2 | Industrials | 13.9% |
| 3 | Healthcare | 13.69% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Materials | 2.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
ATI
ATI
$10.6B
| $470K | 0.03% |
15,750
| – | – |
|
127
Procter & Gamble
PG
$368B
| $470K | 0.03% |
3,100
| – | – |
|
128
Comcast
CMCSA
$124B
| $406K | 0.03% |
11,600
| – | – |
|
|
MDRX
129
DELISTED
Veradigm Inc. Common Stock
MDRX
| $353K | 0.02% |
20,000
| – | – |
|
130
PepsiCo
PEP
$203B
| $307K | 0.02% |
1,700
| – | – |
|
131
Neogen
NEOG
$1.21B
| $305K | 0.02% |
+20,000
| New | +$305K |
|
132
Ooma
OOMA
$358M
| $272K | 0.02% |
20,000
| – | – |
|
133
Baxter International
BAX
$12.2B
| $270K | 0.02% |
5,300
| – | – |
|
134
RTX Corp
RTX
$211B
| $236K | 0.02% |
+2,334
| New | +$236K |
|
135
Health Catalyst
HCAT
$230M
| $213K | 0.01% |
+20,000
| New | +$213K |
|
136
Nu Skin
NUS
$598M
| $211K | 0.01% |
+5,000
| New | +$211K |
|
137
Lantronix
LTRX
$180M
| $173K | 0.01% |
40,000
| – | – |
|
138
Lulu's Fashion Lounge
LVLU
$10.6M
| $157K | 0.01% |
62,555
+42,555
| +213% | +$107K |
|
|
IVC
139
DELISTED
Invacare Corporation
IVC
| $147K | 0.01% |
350,000
| – | – |
|
|
TBHC
140
The Brand House Collective, Inc. Common Stock
TBHC
$33.7M
| $142K | 0.01% |
42,900
-84,333
| -66% | -$278K |
|
141
Adeia
ADEA
$1.65B
| $124K | 0.01% |
13,125
| – | – |
|
142
Ocular Therapeutix
OCUL
$2.26B
| $112K | 0.01% |
40,000
| – | – |
|
143
Ceragon Networks
CRNT
$176M
| $66.9K | ﹤0.01% |
35,000
| – | – |
|
|
EXPR
144
DELISTED
Express, Inc.
EXPR
| $39.2K | ﹤0.01% |
38,400
| – | – |
|
145
Emergent Biosolutions
EBS
$436M
| – | – |
-10,000
| Closed | -$210K |
|
146
Ichor Holdings
ICHR
$562M
| – | – |
-241,100
| Closed | -$5.84M |
|
147
InfuSystem Holdings
INFU
$216M
| – | – |
-20,000
| Closed | -$140K |
|
148
JELD-WEN Holding
JELD
$528M
| – | – |
-10,000
| Closed | -$87K |
|
149
Exagen
XGN
$213M
| – | – |
-81,189
| Closed | -$220K |
|
150
Zumiez
ZUMZ
$305M
| – | – |
-39,200
| Closed | -$844K |
|